Literature DB >> 8542140

Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia.

A Boutten1, M S Dehoux, N Seta, J Ostinelli, P Venembre, B Crestani, M C Dombret, G Durand, M Aubier.   

Abstract

Because interleukin 8 (IL-8) is a potent neutrophil chemotactic and activating cytokine, we investigated IL-8 production in relation to neutrophil migration and elastase release in the human lung during unilateral community-acquired pneumonia (CAP). In 17 patients, the local response in the involved lung was compared with that in the contralateral, noninvolved lung, and with the systemic response. Eight healthy volunteers served as controls. IL-8, total neutrophil elastase (NE), free elastase activity, alpha 1-antitrypsin (alpha 1-AT), and total leukocyte and neutrophil counts were evaluated in bronchoalveolar lavage fluids (BALF). Mean IL-8 concentrations in BALF from the involved lungs of the patients were significantly greater than those in BALF from the noninvolved lung or from controls (p < or = 0.001). By contrast, the serum IL-8 concentration was not different in patients and in controls. Total NE and alpha 1-AT concentrations were increased in BALF from the involved lung as compared with the noninvolved lung or controls (p < or = 0.001). The elastase-inhibitory capacity of alpha 1-AT in BALF was impaired in the involved lung of seven of the 14 patients as compared with the controls, leading to free elastase activity in the involved lung of all patients with CAP. Plasma total NE concentrations were significantly greater in the CAP patients than in the controls. IL-8 concentrations in BALF correlated positively with total leukocyte counts, absolute numbers and percentages of neutrophils, total NE concentrations, and free elastase activity. Our results suggest that during unilateral CAP, locally produced IL-8 may trigger neutrophil accumulation and activation, thus contributing to a local elastase/antielastase imbalance within the site of infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8542140     DOI: 10.1164/ajrccm.153.1.8542140

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  24 in total

Review 1.  Streptococcus pneumoniae.

Authors:  J R Catterall
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

Review 2.  Cytokines in innate host defense in the lung.

Authors:  Robert M Strieter; John A Belperio; Michael P Keane
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Implications of the innate immune response to adenovirus and adenoviral vectors.

Authors:  Seth M Gregory; Shoab A Nazir; Jordan P Metcalf
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

4.  Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa.

Authors:  Avinash Sonawane; Jeevan Jyot; Russell During; Reuben Ramphal
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

Review 5.  Pathobiology of neutrophil-epithelial interactions.

Authors:  Jennifer C Brazil; Charles A Parkos
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

6.  Development of a novel preclinical model of pneumococcal pneumonia in nonhuman primates.

Authors:  Bryan D Kraft; Claude A Piantadosi; Ashlee M Benjamin; Joseph E Lucas; Aimee K Zaas; Marisol Betancourt-Quiroz; Christopher W Woods; Alan L Chang; Victor L Roggli; Craig D Marshall; Geoffrey S Ginsburg; Karen Welty-Wolf
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

7.  Inflammatory responses in blood samples of human immunodeficiency virus-infected patients with pulmonary infections.

Authors:  Natividad Benito; Asunción Moreno; Xavier Filella; José M Miró; Julià González; Tomás Pumarola; María Eugenia Valls; Montserrat Luna; Felipe García; Ana Rañó; Antoni Torres; José M Gatell
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

8.  Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone.

Authors:  Esther Calbo; Montserrat Alsina; Mónica Rodríguez-Carballeira; Josep Lite; Javier Garau
Journal:  Antimicrob Agents Chemother       Date:  2008-04-21       Impact factor: 5.191

9.  Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia.

Authors:  Charles-Edouard Luyt; Alain Combes; Catherine Reynaud; Guillaume Hekimian; Ania Nieszkowska; Marc Tonnellier; Alexandra Aubry; Jean-Louis Trouillet; Maguy Bernard; Jean Chastre
Journal:  Intensive Care Med       Date:  2008-04-18       Impact factor: 17.440

10.  Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia.

Authors:  Julian L Millo; Marcus J Schultz; Conrad Williams; Gerrit J Weverling; Timothy Ringrose; Carolyn I Mackinlay; Tom van der Poll; Christopher S Garrard
Journal:  Intensive Care Med       Date:  2003-11-21       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.